Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of LY231514 With Irinotecan Administered Intravenously Every 21 Days in Patients With Metastatic Cancer

NCT00003711 is registered in ClinicalTrials.gov with San Antonio Cancer Institute as lead sponsor.

NCT NCT00003711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of LY231514 With Irinotecan Administered Intravenously Every 21 Days in Patients With Metastatic Cancer
Lead sponsor
San Antonio Cancer Institute
Phase
Phase 1
Overall status
Completed
Start date
September 30, 1997
Completion date
September 30, 2004
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific